19 results
DEF 14A
ARCT
Arcturus Therapeutics Holdings Inc
1 Oct 19
Definitive proxy
6:07am
in the life sciences sector, and because of legal expertise.
Director Independence
The listing rules of Nasdaq require us to maintain a Board … committee members and compensation committee members must also satisfy the independence criteria set forth in Rule10A-3 and Rule10C-1, respectively
DEFR14A
2k6kyksgfgltieddgt
12 May 22
Revised proxy
5:00pm
8-K
EX-10.1
if40r0df678
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
S-4
9dsa pplt0aj1y
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
S-4/A
ydv zmrw8ra
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
424B3
aez0j3v7 6zq18
12 Apr 19
Prospectus supplement
4:39pm
8-K
EX-1.1
p5cxtqzrlwzlst3h
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-1.1
i8s730mk60bx
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-1.1
hlw99
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
10-K
dww16u7
16 Mar 20
Annual report
11:09am
- Prev
- 1
- Next